Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jun 13:5:213.
doi: 10.3389/fphys.2014.00213. eCollection 2014.

The impact of vitamin D in breast cancer: genomics, pathways, metabolism

Affiliations
Review

The impact of vitamin D in breast cancer: genomics, pathways, metabolism

Carmen J Narvaez et al. Front Physiol. .

Abstract

Nuclear receptors exert profound effects on mammary gland physiology and have complex roles in the etiology of breast cancer. In addition to receptors for classic steroid hormones such as estrogen and progesterone, the nuclear vitamin D receptor (VDR) interacts with its ligand 1α,25(OH)2D3 to modulate the normal mammary epithelial cell genome and subsequent phenotype. Observational studies suggest that vitamin D deficiency is common in breast cancer patients and that low vitamin D status enhances the risk for disease development or progression. Genomic profiling has characterized many 1α,25(OH)2D3 responsive targets in normal mammary cells and in breast cancers, providing insight into the molecular actions of 1α,25(OH)2D3 and the VDR in regulation of cell cycle, apoptosis, and differentiation. New areas of emphasis include regulation of tumor metabolism and innate immune responses. However, the role of VDR in individual cell types (i.e., epithelial, adipose, fibroblast, endothelial, immune) of normal and tumor tissues remains to be clarified. Furthermore, the mechanisms by which VDR integrates signaling between diverse cell types and controls soluble signals and paracrine pathways in the tissue/tumor microenvironment remain to be defined. Model systems of carcinogenesis have provided evidence that both VDR expression and 1α,25(OH)2D3 actions change with transformation but clinical data regarding vitamin D responsiveness of established tumors is limited and inconclusive. Because breast cancer is heterogeneous, analysis of VDR actions in specific molecular subtypes of the disease may help to clarify the conflicting data. The expanded use of genomic, proteomic and metabolomic approaches on a diverse array of in vitro and in vivo model systems is clearly warranted to comprehensively understand the network of vitamin D regulated pathways in the context of breast cancer.

Keywords: 1α,25(OH)2D3; VDR; breast cancer; calcitriol; genomics; vitamin D.

PubMed Disclaimer

References

    1. Abedin S. A., Thorne J. L., Battaglia S., Maguire O., Hornung L. B., Doherty A. P., et al. (2009). Elevated NCOR1 disrupts a network of dietary-sensing nuclear receptors in bladder cancer cells. Carcinogenesis 30, 449–456 10.1093/carcin/bgp005 - DOI - PMC - PubMed
    1. Agadir A., Lazzaro G., Zheng Y., Zhang X. K., Mehta R. (1999). Resistance of HBL100 human breast epithelial cells to vitamin D action. Carcinogenesis 20, 577–582 10.1093/carcin/20.4.577 - DOI - PubMed
    1. Albertson D. G., Ylstra B., Segraves R., Collins C., Dairkee S. H., Kowbel D., et al. (2000). Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat. Genet. 25, 144–146 10.1038/75985 - DOI - PubMed
    1. Alvarez J. A., Chowdhury R., Jones D. P., Martin G. S., Brigham K. L., Binongo J. N., et al. (2014). Vitamin D status is independently associated with plasma glutathione and cysteine thiol/disulfide redox status in adults. Clin. Endocrinol. (Oxf.). [Epub ahead of print]. 10.1111/cen.12449 - DOI - PMC - PubMed
    1. Bauer S. R., Hankinson S. E., Bertone-Johnson E. R., Ding E. L. (2013). Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies. Medicine (Baltimore) 92, 123–131 10.1097/MD.0b013e3182943bc2 - DOI - PMC - PubMed